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Background. Acute Kidney Injury (AKI) is common in elderly people (EP). There is paucity of data on predictor of mortality in EP
with AKI.Objective. This study was done to knowmore about factors associated with inpatient mortality in EP with AKI.Methods.
We retrospectively reviewed medical records of patients aged 65 years or above hospitalized with a diagnosis of AKI at Aga Khan
University Hospital, Karachi, between January 2005 and December 2010. Binary logistic regression models were constructed to
identify factors associated with mortality in EP with AKI. Results. 431 patients had AKI, with 341 (79.1%) having stage I AKI, 56
(13%) having stage II AKI, and 34 (7.9%) having stage III AKI. Out of 431 patients, 142 (32.9%) died. Mortality increased with
increasing severity of AKI. Mortality was 50% (17/34) in AKI stage III, 44.6% (25/56) in AKI stage II, and 29.3% (100/341) in AKI
stage I. Factors associated with increased inpatientsmortality were presence of stage III AKI (OR: 3.20,𝑃 = 0.04, 95%CI: 1.05–9.72),
presence of oliguria (OR: 3.42, 𝑃 = 0.006, 95% CI: 1.42–8.22), and need for vasopressors (OR: 6.90, 𝑃 < 0.001, 95% CI: 2.42–19.65).
Median bicarbonate 18 versus 17 between those who survived and those who died was associated with less mortality (OR: 0.94,
𝑃 = 0.02, 95% CI: 0.89–0.99). History of hypertension (OR: 0.49, 𝑃 = 0.03, 95% CI: 0.25–0.95) and high admission creatinine (OR:
0.68, 𝑃 = 0.01, 95% CI: 0.50–0.91) were also associated with less mortality. Conclusion. Mortality in EP increases with increasing
severity of AKI. Presence of stage III AKI, oliguria, and hemodynamic instability needing vasopressor are associated with increased
mortality. Increased median bicarbonate, presence of hypertension, and high admission creatinine were various factors associated
with decreased inpatient mortality. Increasing age and need for dialysis did not increase mortality in elderly population.
1. Introduction
EP are prone to develop AKI due to comorbid condi-
tions and age-related changes in the kidney. There is age-
related glomerulosclerosis, mesangial expansion, thickening
of glomerular basement membrane, and decrease in the
number of tubules, resulting in reduced renal mass [1–4].
The combination of age-related changes and presence of
comorbid conditions makes EP prone to develop AKI when
exposed to any acute health-related issues. The incidence of
AKI is increasing worldwide [5–7] with increased incidence
in EP [7]. AKI causes morbidity, mortality, and significant
cost to healthcare system. Mortality of AKI in EP varies from
20 to 45% as reported in various studies [7–9]. There is little
work done on factors associated with mortality in AKI in
EP. Identification of factors associated with mortality may
identify risk factors, which when present can lead to worse
outcome. Manipulating these factors may improve mortality
further in the future. With this in mind, this study was
designed to investigate and identify potential factors thatmay
determine mortality in this specific group of patients.
2. Materials and Methods
This retrospective study was conducted at Aga Khan Uni-
versity Hospital, Karachi, Pakistan. Aga Khan University
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Hospital is a tertiary healthcare facility located in the biggest
city in Pakistan. It has 15 inpatient units with a total capacity
of 563 beds and is also the tertiary referral center for advanced
diagnostic procedures and management. This study was
conducted at the Department of Medicine.
Data were collected from the start of 2005 to 2010 for
a period of 5 years after receiving approval from the ethics
review committee of the institution. All patients consented on
admission for publication of their data for research purposes
as per hospital policy. Study population included EP with
AKI. EP were defined as population having age of 65 years
or above [10, 11]. EP with AKI and age of 65 or above were
included in the study. Patients with history of chronic kidney
disease and age below 65 years were excluded. Patients who
have no reference creatinine in the past 3 months were also
excluded. Data on demographics, clinical features, laboratory
investigations, and mortality were noted on a proforma.
Records of the cases were retrieved through codes using
international classification of disease (ICD). The ICD code
for AKI is 584.9. All the files were retrieved through iden-
tification of ICD code for AKI. AKI was defined as any of the
following according to KDIGO guidelines [12]:
(i) Increase in serum creatinine by ≥0.3mg/dl
(≥26.5micromole/l) within 48 hours
(ii) Increase in serum creatinine to ≥1.5 times compared
to baseline, which is known or presumed to have
occurred within the prior 7 days
(iii) Urine volume <0.5ml/kg/h for 6 hours
AKI was further classified into the following stages:
Stage 1. Increase in serum creatinine 1.5–1.9 times compared
to baseline or ≥0.3mg/dl (≥26.5mmol/l) increase and urine
output <0.5ml/kg/h for 6–12 hours.
Stage 2. Increase in serum creatinine 2.0–2.9 times compared
to baseline and urine output <0.5ml/kg/h for ≥12 hours.
Stage 3. Increase in serum creatinine 3.0 times compared
to baseline or increase in serum creatinine to ≥4.0mg/dl
(≥353.6 𝜇mol/l) or initiation of renal replacement therapy
or, in patients below 18 years of age, decrease in eGFR to
<35ml/min per 1.73m2 or anuria for ≥12 hours.
EP were defined as population having age of 65 years or
above [10, 11]. The cohort was assessed for factors associated
with inpatient mortality by dividing it into two groups.
One group included patients who survived and the other
group included patients who died. Mortality comparison for
ages of 65–80 years and >80 years was also done. Ethical
approval was taken from both departmental and hospital
ethics review committee. All patients consented on admission
for publication of their data for research purposes in the
future as per hospital policy.
3. Statistics
A descriptive analysis was done for demographic, clinical,
and radiographic features and results are presented as mean
± standard deviation for quantitative variables and number
(percentage) for qualitative variables. Differences in propor-
tions were assessed by using the Chi-square test or Fisher’s
exact test where appropriate. For contrasts of continuous
variables, independent sample 𝑡-test was used to assess the
difference of means. Multivariable analysis was conducted to
identify the factors of in-hospital mortality in AKI patients.
All analyses were conducted by using the Statistical
Package for Social Sciences (SPSS) (release 16.0, standard
version, copyright © SPSS; 1989-02).
4. Results
476 patients were analyzed. 30 patients having chronic
kidney diseases were excluded. Another 15 patients having
no baseline creatinine in previous three months were also
excluded. At the end, 431 patients who had AKI and who
satisfied our inclusion criteria were analyzed. 431 patients
had AKI, with 341 (79.1%) having stage I AKI, 56 (13%)
having stage II AKI, and 34 (7.9%) having stage III AKI.
Urine routine examination was available for 411 patients. It
showed pyuria in 11 and proteinuria or hematuria in 48 and
was bland in 352. Kidney biopsy was performed in 44 cases,
showing acute tubular necrosis in 8, glomerulonephritis or
vasculitis in 24, and interstitial nephritis in 12. 348 (80.7%)
were aged 65–80 years. 83 patients (19.3%) were aged above
80 years. Out of 431 patients, 250 (58%) were males and 181
(42%) were females. We analyzed various factors that could
affectmortality.These included age, comorbid conditions like
diabetes and hypertension, admission creatinine, peak crea-
tinine, pH, O
2
, CO
2
, HCO
3
, albumin, presence of oliguria,
need for vasopressor, stay in ICU, and severity of AKI. On
univariate analysis, hypertension (𝑃 = 0.055), admission
creatinine (𝑃 = 0.02), peak creatinine (𝑃 = 0.054), AKI
stage III (𝑃 = 0.009), need for ventilation (𝑃 = 0.01), need
for vasopressor (𝑃 < 0.001), need for ICU (𝑃 = 0.004), and
presence of oliguria (𝑃 = 0.001) were found to be associated
with increased mortality (Table 1). 142 patients (32.9%) died.
Mortality varied proportionally with severity of AKI. 144
patients (32.9%) died. Mortality was 50% (17/34) in stage III
AKI, 42.9% (24/56) in stage II AKI, and 29.03% (99/341) in
stage III AKI (Table 1).
However, onmultivariate logistic regression analysis, fac-
tors associated with increased inpatients mortality (Table 3)
included presence of stage III AKI (OR: 3.20, 𝑃 = 0.04, 95%
CI: 1.05–9.72), presence of oliguria (OR: 3.42, 𝑃 = 0.006,
95% CI: 1.42–8.22), and need for vasopressors (OR: 6.90,
𝑃 < 0.001, 95% CI: 2.42–19.65). High median bicarbonate
(OR: 0.94, 𝑃 = 0.02, 95% CI: 0.89–0.99), history of
hypertension (OR: 0.49, 𝑃 = 0.03, 95% CI: 0.25–0.95), and
high admission creatinine (OR: 0.68, 𝑃 = 0.01, 95% CI:
0.50–0.91) were associated with lesser mortality. Significant
number of our patients have low albumin. Interestingly,
unlike chronic kidney disease, hypoalbuminemia in our
cohort did not contribute to increased mortality. Similarly,
the presence of diabetes did not contribute to mortality in
our cohort. Increasing age (65–80 versus >80 years) did not
have any impact on mortality. Furthermore, the need for
hemodialysis was not associated with increased mortality
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Table 1: Descriptive characteristics of study population (𝑛 = 431).
Total Survived, 𝑛 = 289 (67.1%) Died, 𝑛 = 142 (32.9%) 𝑃 value
Age
65–80 years 348 (80.7%) 231 (79.9%) 117 (82.4%) 0.61
>80 years 83 (19.3%) 58 (20.1%) 25 (17.6%)
Length of stay, days, median [IQR] 4 [2–8]
Diabetes 133 (30.9%) 94 (70.7%) 39 (29.3%) 0.32
Hypertension 228 (55.9%) 163 (71.5%) 65 (28.5%) 0.055
Admission Cr, median [IQR] 2.1 [1.4–3.1] 2.2 [1.5–3.3] 2 [1.2–2.8] 0.02∗
Peak Cr 2.8 [2.1–4.1] 2.7 [2–4] 3 [2.2–4.1] 0.054∗
Discharge Cr 1.8 [1.3–2.9] 1.5 [1.1–2.2] 2.7 [1.8–3.6] <0.001∗
pH 7.3 ± 0.29 7.3 ± 0.36 7.3 ± 0.13 0.99
O
2
81.6 ± 21.7 81.6 ± 21.2 81.5 ± 22.7 0.98
pCOâĆĆ 34 ± 15.2 33.9 ± 15.2 15.3 ± 1.6 0.95
Albumin, 𝑛 = 280
<3.5 260 (92.9%) 162 (91.5%) 98 (95.1%) 0.33
>3.5 20 (7.1%) 15 (8.5%) 5 (4.9%)
HCO
3
, 𝑛 = 224
<21 156 (69.6) 92 (68.1) 64 (71.9) 0.65
>21 68 (30.4) 43 (31.9) 25 (28.1)
HCO
3
, median [IQR] 18 [13–23] 18 [15–23] 17 [12–22] 0.12∗
Need for dialysis 20 (4.5) 11 (3.7) 9 (6.2) 0.23
Ventilation 32 (7.2) 15 (5) 17 (11.6) 0.01
Vasopressor 56 (12.6) 15 (5) 41 (28.1) <0.001
Stay in ICU 25 (5.6) 10 (3.3) 15 (10.3) 0.004
Oliguria 63 (14.2) 31 (10.4) 32 (21.9) 0.001
AKI stage 1 341 (79.1%) 241 (70.7%) 100 (29.3%) NS
AKI stage 2 56 (13%) 31 (55.4%) 25 (44.6%) NS
AKI stage 3 34 (7.9%) 17 (50%) 17 (50%) NS
Outcome
Survived 299 (67.1)
Died 146 (32.9)
Table 2: Stages, mode of renal replacement therapy, outcome of patient on renal replacement therapy, and inpatient mortality in patients
with AKI.
Stages of AKI Mode of renal replacement therapy Outcome of patients needing renalreplacement therapy Inpatient mortality
Stage I AKI
Stage II AKI
Stage III AKI
341 (79.1%)
56 (13%)
34 (7.9%)
Intermittent hemodialysis = 15 patients
Continuous renal replacement therapy = 5
Patients needing renal replacement
therapy = 20
Died = 9
Survived = 11
Full recovery = 6
Partial recovery = 3
Chronic kidney disease needing
dialysis = 2
Survived = 299 (67.1%)
Died = 146 (32.9%)
in our cohort. At the same time, there were no survival
benefits with use of hemodialysis (11 died and 9 survived).
20 patients needed dialysis. 15 patients were treated with
intermittent hemodialysis and 5 received continuous renal
replacement therapy. 6 patients needed 10 sessions, 2 patients
needed 9 sessions, and 5 patients needed 8 sessions. 2 patients
needed three times per week upon discharge. 11 patients
needing renal replacement therapy survived in comparison
to 9 patients who died. 6 patients needing renal replacement
therapy recovered full renal function. 3 had partial recovery
with no need for dialysis. 2 patients developed stage 5 chronic
kidney disease and were dialysis-dependent till 6 months of
follow-up (Table 2).
5. Discussion
AKI is common worldwide. Incidence rates have been
reported in many studies varying within an average of 23.8
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Table 3: Multivariable analysis of factor predicting outcome (mor-
tality) in AKI patients.
Odds ratio [95% CI] 𝑃 value
Factors predicting worse outcome
Oliguria
No 1.0 0.006
Yes 3.42 [1.42–8.22]
Vasopressor
No 1.0
<0.001
Yes 6.90 [2.42–19.65]
AKI stage III versus AKI stages I and II 1.0 0.04
3.20 [1.05–9.72]
Factors predicting better outcome
HTN
No 1.0 0.03
Yes 0.49 [0.25–0.95]
Admission Cr 0.68 [0.50–0.91] 0.01
Median bicarbonate 0.94 [0.89–0.99] 0.02
Factors having no effect on the outcome
Peak Cr 1.04 [0.87–1.25] 0.63
Albumin 0.66 [0.41–1.06] 0.08
DM
No 1.0 0.51
Yes 0.78 [0.37–1.63]
cases per 1000 discharges [6, 13, 14] and there is 11% yearly
increase between 1991 and 2001 [6]. Like other age groups, EP
are alsomore prone to developAKI due tomultiple comorbid
conditions and age-related changes in the kidney. As a result,
the incidence of AKI has increased significantly in EP [7].
AKI has been associatedwith significantmorbidity,mortality,
and enormous cost to the health system.
Inpatient hospitalmortality in patients withAKI has been
reported to be 10.8%–42.8% in various studies [7, 9, 15–17].
We found mortality of around 32.9%, which is comparable
to the results found in other studies. Mortality in AKI is
highly variable due to a variety of reasons. It can be low in
community-acquired AKI (19.6%) as compared to hospital-
acquired AKI (42.8%) [16]. Similarly, high mortality ranging
from 66% to 71.5% has been reported in patients admitted to
ICU with AKI [13, 18]. Mortality is even worse (81%) if AKI
develops after 7 days of ICU admission [18]. AKI due to sepsis
has very high mortality of 74% when compared to nonseptic
AKI, where mortality is 45% [19]. Our mortality was 32.9%,
which is comparable to reported 10.8%–42.8% internationally
[7, 9, 15–17]. However, it is lower than ICU, hospital-acquired,
and sepsis-related AKI. This might be because we included
community-acquired AKI and only few (5.6%) patients of
our cohorts were from ICU. Moreover, a bulk of our patients
(79.1%) were having mild stage I AKI.
For every disease, it is important to know its prognostic
factors that can affect the outcome. A couple of studies
are available to look for prognostic factors for mortality in
patients with AKI [20–22]. However, all these studies are
done in various age group patients including elderly patients.
Prerenal AKI is usually due to decrease in effective circula-
tion, which if not corrected leads to acute tubular necrosis.
Theoretically, the chances of conversion from prerenal failure
to intrinsic renal failure are more in elderly patients due to
the presence of comorbid conditions and age-related changes.
We found that the use of vasopressors in EP with AKI has
propensity to die. Korula et al. also found the use of vaso-
pressor to be associated with increased 28-daymortality [22].
Similarly, Uchino et al. [23] also found that use of vasopressor
increases odds of mortality. Hypotension in event of AKI
led to increased mortality in various studies [21, 24, 25]. We
also found that low blood pressure during event of AKI can
lead to increased mortality. Presence of hypertension in our
cohort exerted a beneficial effect on mortality. We assume
that this could be due to better perfusion of the kidney.
However, this warrants further investigations in prospective
studies. Patients with AKI and having low blood pressure due
to volume depletion can benefit from fluid resuscitation to
achieve good mean arterial pressure.This will have beneficial
outcome on mortality. We found the need for ICU and
mechanical ventilation to be significantly associated with
increased mortality on univariate analysis. However, these
facts were not reproduced when analyzed through logistic
regression analysis. This may be due to the fact that very
small proportion of our cohort needed ICU care. We found
increased mortality with increasing severity of AKI. In fact,
mortality was 50% in stage III AKI in our cohort.
Monitoring urine output is important to identify patients
at risk of AKI as changes in creatinine may take time
to appear. Presence of oliguria has got worst prognostic
implications. We found that oliguria in EP with AKI was
significantly associated with increasedmortality. Oliguria has
been found by other colleagues as a predictor of mortality
[19, 21, 24, 26]. Oliguria and abnormal creatinine when used
together have been shown to predict the highest mortality as
shown in a cohort of 32,000 patients [14]. AKI causes various
complications including metabolic acidosis. We found that
the median bicarbonate in those who survived was high
as compared to those who died. High median bicarbonate
has a beneficial effect on reducing mortality. We found high
admission creatinine to be associated with less morality.
This could be due to earlier alertness of clinician to start
goal-directed therapy. Alternatively this may point to more
community acquired AKI in our cohort, which has better
prognosis. This finding needs further assessment preferably
through prospective studies.
Although diabetes was also present in a significant num-
ber of patients in our cohort, analysis of our data did not
show any impact of diabetes on mortality. Low albumin has
been shown to increase mortality in chronic kidney disease
patients [27, 28]. However, we failed to show that low albumin
leads to increased mortality in EP with AKI in our study.
The studies we cited so far for mortality and its predictors
included all age groups from young to elderly. None of
them were specifically done on elderly population. Various
prognostic factors we found which could relate to mortality
in the elderly were also reported for other age groups as
discussed. One may think that, in presence of age-related
changes, EP may do worse. However, we found interesting
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trend that increasing age within elderly populations was not
associated with worse outcome. The difference in mortality
in our cohort with increasing age (65–80 years versus >80
years) was not significant. Rather the mortality of 32.9% was
comparable to other age groups, wheremortality ranged from
10.8% to 42.8% [7, 9, 15–17]. Our literature search showed that
only few studies are done in elderly populations. Van Den
Noortgate et al. did a retrospective analysis of postcardiac
surgery AKI in EP who needed dialysis. They showed similar
outcome between elderly and young populations in terms of
mortality [29]. In our study, we found a similar trend and
need for hemodialysis did not have any impact on inpatient
mortality. The absence of a relationship between age and
poor outcome in the elderly developing AKI in the intensive
care unit has already been confirmed in another study [30].
Pasciial and Llan˜o [8] analyzed mortality in EP with AKI.
They compared age above 80 years, age of 65–79 years, and
age below 65 years. They found no difference in mortality
across all the age groups. From this, we can assume that
outcome of AKI in terms of mortality is similar to other age
groups.Therefore, if EP need dialysis in an event of AKI, they
should not be discriminated on the basis of age.
6. Strength and Limitation of the Study
The strength of this study is that it is one of the few studies
in elderly Pakistani Asian population, which analyzed a large
cohort of patients for prognostic factors associated with
mortality. We acknowledge that there are several limitations
in this study. This data is retrospective and is from a single
center. We would have liked to report etiology and classifi-
cation of AKI as prerenal, renal (acute tubular necrosis), and
postrenal if the study was done prospectively. The definition
of elderly person has been variable and as a result the findings
of this study can be applied to the age groups mentioned
in this study only. We also acknowledge that using code to
identify AKI can lead to error and may miss some data. We
admit that lack of baseline creatinine in previous 3 months
could have excluded some patients withAKI fromour cohort,
resulting in selection bias. However, the number of such
patients was only 15 and we could not classify them as AKI
or chronic kidney disease even from the review of notes. We
acknowledge that there was a lack of long-term follow-up to
show the long-term effect of AKI on morbidity and mortality
in EP.
7. Conclusion
We conclude from this study that mortality in EP increases
with increasing severity of AKI. Severe AKI (stage III),
oliguria, and hemodynamic instability needing vasopres-
sor were associated with increased mortality. Presence of
hypertension, high median carbonate, and high admission
creatinine were associated with beneficial effect on mortality.
Mortality of AKI in EP is comparable to other studies.
Moreover, increasing age within elderly population is not
associated with worse outcome. Age is not a particularly poor
prognostic sign, and outcome seems to be acceptable for very
old patients with AKI. Therefore, EP with above risk factors
should get meticulous resuscitation and renal support under
close monitoring. Furthermore, acute dialysis should not be
withheld from patients solely because of their increasing age.
Abbreviations
AKI: Acute Kidney Injury
EP: Elderly people.
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